U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07568964) titled 'Evaluation of Probiotics' Effect on Atrial Fibrillation Recurrence in Patients Undergoing Cardioversion' on April 10.
Brief Summary: The aim of this clinical study is to evaluate the efficacy and tolerability of probiotics on atrial fibrillation recurrence.
Study Start Date: May 10
Study Type: INTERVENTIONAL
Condition:
Atrial Fibrillation (AF)
Intervention:
DRUG: Anticoagulant Therapy
Drug: The standard of care for AF management directly following cardioversion Include anticoagulant therapy for at least 4 weeks, rate control therapy, rhythm control therapy, or both as per clinical and guideline decisions.
DRUG: Probiotics caps...